FATE THERAPEUTICS INC (FATE) Return on equity 2016–2025
FATE THERAPEUTICS INC (FATE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-65.8%FY2025 · since FY2016: -45.7% → -65.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -65.8% | -7.4 pp |
| FY2024 | -58.4% | -14.8 pp |
| FY2023 | -43.7% | +14.5 pp |
| FY2022 | -58.2% | -27.0 pp |
| FY2021 | -31.3% | +13.8 pp |
| FY2020 | -45.1% | -5.0 pp |
| FY2019 | -40.1% | +1.4 pp |
| FY2018 | -41.5% | +14.1 pp |
| FY2017 | -55.6% | -9.9 pp |
| FY2016 | -45.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More FATE financial trends
FATE RevenueFATE Net incomeFATE Net marginFATE Gross profitFATE Gross marginFATE Operating incomeFATE Operating marginFATE Operating cash flowFATE Free cash flowFATE Capital expendituresFATE Stock buybacksFATE Dividends paidFATE Total assetsFATE Total liabilitiesFATE Shareholders’ equityFATE overview →